Mind Club

Data as of 11.07.2026 · Primary sources linked · NOT INVESTMENT ADVICE

Disease Pipeline Tools Obesity

Obesity

Programs, trials, and reported weight change for obesity and overweight.

Data as of 11.07.2026

All studies

Survodutide

ELEVATE-LIVER: A Study to Test Whether Survodutide Helps Improve Heart Structure and Function in People With Overweight or Obesity and Fatty Liver Disease

Boehringer Ingelheim · Phase 3 · Not yet recruiting · Enrollment 600

NCT07850063

Participants reaching a weight loss threshold

Participants reaching threshold, %

Source: Cited trial source. The denominator is the source figure, when it states one.

No selected arm reports a responder percent.

Show as table
Arm≥5%≥10%≥15%≥20%
Survodutide armn/rn/rn/rn/r
Placebo armn/rn/rn/rn/r

Not shown

  • Survodutide arm: endpoint not reported
  • Placebo arm: endpoint not reported